Salta al contenuto principale

Towards next-generation nanotherapeutics: lessons learned and new challenges

Data evento: Dal al - 14:15
Dove: NEST Meeting Room
Testo evento

ONLINE: https://link.nano.cnr.it/NanoColloquia
At the end of the colloquium, there will be a coffee break and refreshments to continue the conversation.

Once connected, please switch off your microphone and camera.

If you have questions, please use the chat to ask for attention.

Speaker: Francesco Cardarelli - Scuola Normale Superiore

Nanomedicine promises to improve therapeutic outcomes through the rational design of nanoscale drug carriers. Yet our ability to engineer these systems often exceeds our understanding of the physical state of their cargo and its fate in biological environments. Connecting formulation properties with drug release, intracellular availability and therapeutic action therefore remains a central challenge.

In this talk, I will discuss these questions using clinically established liposomal formulations, including Doxil and Onivyde, as case studies. Starting from observations in cultured cells and three-dimensional tumour models, I will highlight why drug accumulation does not necessarily translate into intracellular bioavailability. I will then present an approach based on fluorescence lifetime measurements and phasor analysis that exploits the intrinsic fluorescence of drug molecules to probe their supramolecular organisation without additional labelling. By distinguishing free, membrane-associated and crystallised drug populations, this approach reveals aspects of formulation identity that complement conventional structural characterisation.

Finally, I will discuss the translation of these findings into dedicated instruments and screening platforms, alongside opportunities to extend their application to other therapeutic cargos. Together, these developments illustrate how quantitative optical measurements can help connect nanoscale formulation design with molecular understanding, supporting the development and assessment of the next generation of nanotherapeutics.

 

Host: Pisa Nano Colloquia Committee

Seminar @ CNR Nano

Data ultimo aggiornamento: